Difficulty: Medium
Average Score: 84%
Practice
One focus of collaborative care of patients with AD is
Correct answer
B
Rationale
In caring for patients with Alzheimer's Disease (AD), drug therapy for cognitive problems and undesirable behaviors is a crucial aspect of collaborative care. The correct answer, option B, is the most appropriate because medications can help manage symptoms such as memory loss and behavioral changes associated with AD. Drugs like cholinesterase inhibitors and memantine are commonly used to improve cognitive function and manage behavioral symptoms.
Option A, replacement of deficient acetylcholine in the brain, is incorrect because while acetylcholine levels are reduced in AD, simply replacing it has not been shown to effectively treat the disease.
Option C, the use of memory-enhancing techniques to delay disease progression, is incorrect because while cognitive stimulation activities may benefit patients in the early stages, they do not alter the course of the disease.
Option D, prevention of other chronic diseases that hasten the progression of AD, is incorrect as it focuses on general health measures rather than specific AD treatment.
Educationally, understanding the rationale behind the correct answer helps students grasp the importance of pharmacological interventions in managing AD symptoms. It also emphasizes the need for evidence-based practices in dementia care, highlighting the limitations of non-pharmacological approaches in altering disease progression. This question reinforces the significance of tailored treatment plans and interdisciplinary collaboration in providing optimal care for patients with neurological disorders.
Option A, replacement of deficient acetylcholine in the brain, is incorrect because while acetylcholine levels are reduced in AD, simply replacing it has not been shown to effectively treat the disease.
Option C, the use of memory-enhancing techniques to delay disease progression, is incorrect because while cognitive stimulation activities may benefit patients in the early stages, they do not alter the course of the disease.
Option D, prevention of other chronic diseases that hasten the progression of AD, is incorrect as it focuses on general health measures rather than specific AD treatment.
Educationally, understanding the rationale behind the correct answer helps students grasp the importance of pharmacological interventions in managing AD symptoms. It also emphasizes the need for evidence-based practices in dementia care, highlighting the limitations of non-pharmacological approaches in altering disease progression. This question reinforces the significance of tailored treatment plans and interdisciplinary collaboration in providing optimal care for patients with neurological disorders.